Role on angiotensin-converting enzyme inhibitors in the prevention of chronic heart failure
N G Poteshkina , Ekaterina Vital'evna Pravdivtseva , A M Svanadze , N G Poteshkina , E V Pravdivtseva , A M Svanadze
Russian Medicine ›› 2011, Vol. 17 ›› Issue (5) : 50 -53.
Role on angiotensin-converting enzyme inhibitors in the prevention of chronic heart failure
| [1] |
Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т. и др. // Сердечная недостаточность. - 2003. - Т. 4, № 3. - С. 116-121. |
| [2] |
Васильева А. Д. // Рус. мед. журн. - 1999. - Т. 7, № 15. - С. 739-744. |
| [3] |
Лопатин Ю. М. // Справочник поликлинического врача. - 2007. - № 11. - С. 35-40. |
| [4] |
Сайт медицины критических состояний. Кардиошкола. - URL: http://www.critical.ru/CardioSchool/index.php. Дата обращения: 16.10.2010. |
| [5] |
Стуров Н. В. // Трудный пациент. - 2006. - № 10. - С. 7-11. |
| [6] |
Тхостова Э. Б. // Рус. мед. журн. - 2001. - Т. 9, № 18. - С. 742-746. |
| [7] |
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evedence of heart failure // Lancet. - 1993. - Vol. 342. - P. 821-828. |
| [8] |
Ambrosioni E., Borghi C., Magnani B. et al. // N. Engl. J. Med. - 1995. - Vol. 332. - P. 80-85. |
| [9] |
Borghi C., Ambrosioni E., Magnani B. // Am. J. Cardiol. - 1996. - Vol. 78, N 3. - P. 317-322. |
| [10] |
Borghi C., Marino P., Zardini P. et al. // Am. J. Hypertens. - 1997. - Vol. 10. - P. 247S-254S. |
| [11] |
Chinese Cardiac Study (CCS-1) Collaborative Group. Oral captopril versus placebo among 14,962 patients with suspected acute MI: a multicenter, randomized, double-blind, placebo-controlled clinical trial // Chin. Med. J. - 1997. - Vol. 110. - P. 834-838. |
| [12] |
Dickstein K., Kjekshus J. // Lancet. - 2002. - Vol. 360. - P. 752-760. |
| [13] |
The EUROPA investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised double-blind, placebo-controlled, multicentre trial (the EUROPA study) // Lancet. - 2003. - Vol. 362. - P. 782-788. |
| [14] |
Ferrari R. // Arch. Intern. Med. - 2006. - Vol. 166. - P. 659-666. |
| [15] |
Foy S. G., Crosier I. G., Turmer J. G. et al. // Am. J. Cardiol. - 1994. - Vol. 73. - P. 1180-1186. |
| [16] |
Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction // Lancet. - 1994. - Vol. 343. - P. 1115-1122. |
| [17] |
Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Six-month effects of early treatment with lisinopril and transdermal glyceril trinitrate singly and together withdrawn six-weeks after acute myocardial infarction: the GISSI-3 trial // J. Am. Coll. Cardiol. - 1996. - Vol. 27. - P. 337- 344. |
| [18] |
Hall A. S., Winter C., Bogle S. M. et al. // J. Cardiovasc. Pharmacol. - 1991. - Vol. 18, N 2. - P. S105-S109. |
| [19] |
Jeffrey S. Borer. // Eur. Heart J. - 2007. - Vol. 9 (suppl. E). - P. E2-E9. |
| [20] |
Kim Fox. // Eur. Heart J. - 2008. - Vol. 10 (suppl. G). - P. G4-G12. |
| [21] |
Kjoller-Hansen L., Steffensen R., Grande P. // J. Am. Coll. Cardiol. - 2000. - Vol. 35, N 4. -P. 881-889. |
| [22] |
Kjoller-Hansen L., Steffensen R., Grande P. // Am. Heart. J. - 2004. - Vol. 148. - P. 475-480. |
| [23] |
Pfeffer M. A., Braunwald E., Moye L. A. et al. // N. Engl. J. Med. - 1992. - Vol. 327. - P. 669-677. |
| [24] |
Yusuf S., Sleight P., Pogue J. et al. // N. Engl. J. Med. - 2000. - Vol. 342. - P. 145-153. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
